Invus Opportunities

Invus Opportunities, established in 2008, is a New York-based venture capital firm. It is affiliated with The Invus Group, an equity investment firm founded in 1985 with over $8 billion in evergreen capital. Invus Opportunities focuses on collaborating with leading management teams and investors in private transactions worldwide. With a distinct heritage and capital base, the firm offers a unique perspective to support growing companies and investor groups aiming to create enduring value. Invus Opportunities participates in financing rounds as both a lead investor and a co-investor in syndicated deals, currently managing over $1.5 billion.

Bryan Kim

Partner at Invus Opportunities

50 past transactions

Rain

Series B in 2025
Rain Technologies Inc. is a financial technology company based in Los Angeles, California, founded in 2019. The company develops applications aimed at enhancing employees' financial health by providing them with on-demand access to their earned wages. Rain's platform integrates with existing payroll systems, allowing employees to withdraw portions of their earned wages at any time, rather than waiting for the traditional payday. This service is offered as a voluntary benefit at no cost to employers. The Rain Instant Pay app not only facilitates wage access but also includes features such as overdraft protection through a checking account option, notifications for upcoming bills, and various budgeting and saving tools. By providing an alternative source for cash, Rain helps businesses support their employees in managing finances more effectively and avoiding reliance on payday loans.

MedinCell

Post in 2025
MedinCell S.A. is a pharmaceutical company based in Jacou, France, that specializes in developing long-acting injectable drug delivery systems using its proprietary BEPO technology. This innovative approach employs biocompatible materials to create formulations that allow for controlled and sustained release of active pharmaceutical ingredients. The company is advancing several product candidates, including mdc-IRM, a subcutaneous injection for schizophrenia currently in Phase III trials, and mdc-CWM, an intra-articular injection aimed at treating pain and inflammation. Additionally, MedinCell is exploring various formulations in research, such as mdc-WWM for contraception and mdc-ANG for central nervous system disorders. The firm focuses on optimizing the efficiency and accessibility of medical treatments across different therapeutic areas through its ongoing research and development efforts.

Zenflow

Series C in 2024
Zenflow, Inc. is a medical device company based in San Francisco, California, that specializes in providing innovative solutions for men suffering from benign prostatic hyperplasia (BPH) symptoms. Founded in 2014 by a team of Stanford University Biodesign Fellows in collaboration with leading urologists, the company aims to address the significant unmet clinical need for effective urinary obstruction treatments. Zenflow's primary product is a spring-like device designed to gently prop open the urethra, restoring its normal function without damaging surrounding tissues. This approach prioritizes patient comfort and minimizes invasiveness, offering a less painful alternative to traditional treatments for urinary obstruction caused by an enlarged prostate.

Vinted

Secondary Market in 2024
Vinted is an online marketplace that focuses on promoting second-hand fashion as a preferred choice for consumers. The platform allows users, primarily targeting girls and women, to buy, sell, and swap clothing, accessories, and lifestyle items in a peer-to-peer environment. Vinted enhances the shopping experience by incorporating an online chatting feature, facilitating communication between users and making transactions simpler and more efficient. With a mobile-first approach, Vinted aims to make second-hand shopping accessible and cost-effective for its community.

Mirador Therapeutics

Series A in 2024
Mirador Therapeutics specializes in developing precision medicine technologies to tackle immune-mediated inflammatory and fibrotic diseases. The company's core offering is a proprietary data analytics engine that integrates comprehensive patient molecular profiles, pinpoints novel therapeutic targets, and facilitates the creation of targeted diagnostics. This enables researchers and healthcare providers to tailor treatments to individual patients' genetics, potentially enhancing outcomes for those with chronic conditions.

Mission Lane

Venture Round in 2024
Mission Lane LLC is a fintech company focused on providing credit card services to subprime consumers. Founded in 2018 and headquartered in Atlanta, Georgia, with additional offices in several U.S. states and Canada, Mission Lane utilizes advanced technology, data analytics, and machine learning to enhance its offerings. The company provides digital self-service tools that help customers manage their accounts and work towards improving their credit scores. By prioritizing transparency and user-friendly terms, Mission Lane aims to deliver a dignified customer experience, making it easier for individuals to access fair credit options and rebuild their financial lives.

Mynd

Venture Round in 2023
Mynd is a technology-driven property management company specializing in single-family rental properties. It offers a suite of services, including property marketing, tenant screening, rent collection, maintenance, and accounting, to help investment property owners efficiently manage their assets and maximize returns. The company leverages technology and data analytics to enhance property performance, ensure timely communication, and provide property owners with real-time information and financial reports via its digital platforms.

Presidio Medical

Series C in 2023
Presidio Medical, Inc. is a clinical-stage medical device company based in South San Francisco, California, that focuses on developing a neuromodulation technology platform aimed at treating chronic pain and other disorders affecting neuronal activity. Founded in 2017, the company is dedicated to creating a new class of therapeutic medical devices through its innovative bioelectronic medicine. This platform is designed to provide patients with effective remedies for conditions related to neural activity, positioning Presidio Medical at the forefront of advancements in medtech and bioengineering.

Rain

Series A in 2023
Rain Technologies Inc. is a financial technology company based in Los Angeles, California, founded in 2019. The company develops applications aimed at enhancing employees' financial health by providing them with on-demand access to their earned wages. Rain's platform integrates with existing payroll systems, allowing employees to withdraw portions of their earned wages at any time, rather than waiting for the traditional payday. This service is offered as a voluntary benefit at no cost to employers. The Rain Instant Pay app not only facilitates wage access but also includes features such as overdraft protection through a checking account option, notifications for upcoming bills, and various budgeting and saving tools. By providing an alternative source for cash, Rain helps businesses support their employees in managing finances more effectively and avoiding reliance on payday loans.

Ziteo Medical

Seed Round in 2023
Ziteo Medical is focused on innovating computed tomography systems to enhance cancer detection and treatment. The company is developing a portable and robotic medical imaging system designed to improve the diagnosis and localization of tumors. This technology aims to facilitate early detection of curable tumors, enabling patients to receive appropriate and timely treatment for cancer. By reimagining traditional imaging methods, Ziteo Medical seeks to advance the effectiveness of cancer care.

SpringWorks Therapeutics

Post in 2022
SpringWorks Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing medicines for underserved patient populations affected by rare diseases and cancer. The company employs a precision medicine approach and has a diverse portfolio of small molecule targeted oncology products. Its lead candidate, nirogacestat, an oral gamma secretase inhibitor, is currently in Phase III clinical trials for desmoid tumors. Additionally, SpringWorks is advancing several other product candidates, including mirdametinib, an oral MEK inhibitor in Phase IIb trials for neurofibromatosis type 1-associated plexiform neurofibromas, and various combinations involving nirogacestat for multiple myeloma. The company has established collaborations with organizations such as BeiGene, GlaxoSmithKline, and Allogene, aimed at enhancing the development of its therapies. Founded in 2017 and headquartered in Stamford, Connecticut, SpringWorks is committed to unlocking the potential of its pipeline to provide innovative solutions for patients suffering from cancer and rare diseases.

Hone

Venture Round in 2022
Hone Group Inc., established in 2018, is a San Francisco-based company that specializes in live online leadership and management training. It offers a development platform that empowers organizations to enhance their employees' soft skills, including communication, team building, and conflict management. Hone's platform facilitates expert-led small group training, peer learning, and continuous reinforcement, while also providing data-driven insights to measure and improve training impact.

Ablative Solutions

Series D in 2022
Ablative Solutions, Inc. is a clinical-stage medical device company focused on developing innovative treatments for hypertension. Incorporated in 2011 and headquartered in San Jose, California, with an additional office in Kalamazoo, Michigan, the company manufactures the Peregrine System, an endovascular catheter designed for the minimally invasive delivery of diagnostic and therapeutic agents into the perivascular space surrounding peripheral blood vessels. This technology provides a safe and effective alternative to traditional surgical renal denervation, aiming to reduce blood pressure in patients with hypertension that is not well controlled. By using alcohol as a neurolytic agent, Ablative Solutions' infusion catheter may offer significant advantages over energy-based systems, making it a promising option for managing hypertension and related conditions caused by an overactive sympathetic nervous system.

Super

Series C in 2022
Super is a social commerce platform that enables leaders to become self-made entrepreneurs and builds logistics networks. The company features Superagen, an agent-led commerce group buying that enables community leaders to become retailers within their communities.

Booster

Series D in 2022
Booster is a mobile energy delivery company based in San Mateo, California, specializing in providing alternative and conventional fuels directly to truck fleets. Founded in 2015, the company offers a unique service that allows customers to access a full-service gas station on wheels through a mobile application. Users can pin their vehicle's location to receive a full tank of fuel while they continue working, effectively reducing road congestion and saving time. Booster has served over 120,000 customers and more than 300 businesses, enabling them to collectively save over eight million miles and four million pounds of CO2 emissions. Additionally, the service allows businesses to reclaim more than 31,000 labor hours and save significant costs related to fuel and vehicle wear and tear.

Xendit

Series D in 2022
Xendit is a Southeast Asian fintech company that specializes in providing payment infrastructure primarily in Indonesia and the Philippines. Founded in 2014 by Moses Lo, Tessa Wijaya, Bo Chen, and Juan Gonzalez, Xendit offers a robust payment gateway platform that enables businesses to accept various forms of payments, including bank transfers, virtual accounts, and credit cards. The company simplifies payment processes through a suite of world-class APIs and an intuitive dashboard, allowing businesses to efficiently manage transactions, disburse payroll, and access loan services while also detecting fraud. By streamlining these financial operations, Xendit supports the growth of businesses in the region.

Learn In

Series A in 2022
Learn In offers an upskilling-as-a-service platform designed to help companies bridge the skills gap among their workforce. The platform allows organizations to provide employees with opportunities for learning sabbaticals, enabling them to acquire essential new skills relevant to a rapidly changing job market. Learn In focuses on delivering online, cost-effective training programs and traditional degree options, particularly in high-demand areas such as data science and software engineering. By facilitating employee development, Learn In aims to enhance engagement and retention within organizations, ensuring that both employers and employees can adapt to evolving workplace needs.

Klarity

Series A in 2022
Klarity is a technology company that specializes in automating the contract review process through advanced software solutions. Founded by a Harvard lawyer and an MIT Computer Science graduate, Klarity's platform streamlines the review of customer contracts in accordance with ASC 606 and IFRS 15 standards. Utilizing machine learning and artificial intelligence, the software normalizes contract review controls with a standardized checklist, identifies clauses that could impact revenue, and documents the technical implications of revenue recognition. Additionally, Klarity organizes and stores all relevant contract documents, such as master service agreements and invoices, in a single repository. This comprehensive approach allows organizations to enhance compliance and accelerate sales processes, minimizing the need for manual contract reviews.

Bolt

Series E in 2022
Bolt is a company dedicated to enhancing e-commerce by providing a streamlined checkout experience. Founded in 2014 and headquartered in San Francisco, Bolt offers a platform that enables retailers to facilitate secure, one-click checkouts for their customers, eliminating the need for passwords or repeated personal information. This approach not only simplifies the purchasing process but also improves conversion rates and customer retention for businesses. A growing number of retailers, including well-known brands such as REVOLVE, Casper, Badgley Mischka, and Benefit Cosmetics, utilize Bolt's services to meet the demand for efficient and user-friendly online shopping experiences. By democratizing commerce, Bolt aims to strengthen the connection between retailers and their customers.

Evenly

Venture Round in 2022
Evenly is a technology platform that specializes in orthodontics, aiming to enhance oral health and wellness through innovative solutions. Founded in 2019 and headquartered in Washington, D.C., the company leverages AI technology and 3D printing to deliver precise orthodontic treatments, including advanced Invisalign options. Its platform allows for remote treatment management, offering patients regular check-ins with orthodontists and clinical experts. By integrating these technologies, Evenly seeks to improve the overall patient experience and accessibility to high-quality orthodontic care across the country.

Jupiter

Series C in 2021
Jupiter is a digital banking app with one simple aim – to deliver a banking experience that keeps pace with you. We help you cut through the banking jargon, offer smart insights based on your spending, and provide you with a range of new-age features to enable you to make sense of your finances.

Figment Capital

Series C in 2021
Figment Networks Inc. is a leading blockchain infrastructure and software provider based in Toronto, Canada, established in 2018. The company develops and operates an open-source crypto network, focusing on enhancing community engagement through tools that facilitate understanding of network health and performance for informed staking decisions. Figment supports various crypto networks, including Tezos, Cosmos, Livepeer, and Horizen. It offers a comprehensive suite of services, such as enterprise-grade node and staking infrastructure, the Hubble Web 3 explorer, and DataHub developer APIs, aimed at simplifying the use, development, and governance of blockchains for token holders and developers alike. Additionally, Figment publishes open-source software and economic research to further benefit the blockchain community.

Dray Alliance

Series B in 2021
Dray Alliance is transforming the drayage trucking industry with its innovative technology platform that streamlines container deliveries to warehouses. By digitizing the container trucking process, the platform enhances transparency and predictability while reducing friction in each stage of delivery. It connects shippers, carriers, and truckers in real-time, ensuring efficient coordination. The platform also standardizes drayage rates to eliminate haggling, provides performance reviews and random inspections to uphold quality, and optimizes return trips to enhance operational efficiency. By focusing on data-driven solutions, Dray Alliance enables import and export shippers to effectively plan and manage the transportation of their products from ports to warehouses.

Claroty

Series E in 2021
Claroty Ltd. is an industrial cybersecurity company based in New York, established in 2014. It specializes in operational technology (OT) security, providing a platform that helps organizations protect and optimize their OT, IoT, and IIoT assets. Claroty's services focus on discovering critical data within industrial networks, including industrial control systems and supervisory control and data acquisition (SCADA) systems. The company's platform integrates seamlessly with existing infrastructure to deliver comprehensive cybersecurity controls, including visibility, threat detection, risk and vulnerability management, and secure remote access. This approach enables organizations to enhance the safety and reliability of their assets and networks while minimizing downtime and improving operational efficiency.

Affinity

Series C in 2021
Affinity is a relationship intelligence platform built to expand and evolve the traditional CRM. Affinity instantly surfaces all of your team's data and shows you who is best suited to make the crucial introductions you need to close your next big deal. Using AI and natural language processing, Affinity helps your team curate and grow its network by unlocking introductions to decision makers and auto-populating your pipeline to increase deal flow. -- Leverage your network: Map out your team's relationship graph to most effectively source the next big deal -- VCs, level up your portfolio: Ally with your portfolio companies and discover how you can introduce them to key prospects and help them raise their next round -- Startups, get the intro: Map out your team's relationship graph. Discover the entire rolodex of prospects your investors and advisors are connected to and unearth valuable introductions -- Reduce complexity: Get rid of spreadsheets for contact management and receive instant updates related to your pipeline as your team works -- Effectively manage pipeline: Keep track of meetings, manage follow-ups, and receive instant updates related to your pipeline as your team works It's time to adopt a CRM that makes your job easier and maximizes your team and investor's most valuable asset - their networks. Affinity has raised $13.5MM led by 8VC (Joe Lonsdale: Palantir, Addepar, OpenGov), Sway Ventures, Pear Ventures, Great Oaks Venture Capital & Western Technology Investment.

FireHydrant

Series B in 2021
FireHydrant, Inc., established in 2018 and based in New York, specializes in incident management software. Its platform streamlines IT disaster recovery, offering features like impact reports, recent changes tracking, incident role management, and integrated alerts. The company's solutions also include incident response process automation, retrospective analysis, and analytics, helping businesses consistently manage and resolve incidents.

Nym

Venture Round in 2021
Nym Health Inc., established in 2017 and headquartered in Boston, Massachusetts, specializes in medical coding technology for healthcare facilities. Its core product, Nym, automates revenue cycle management by interpreting clinical language in patient charts and accurately assigning medical charge codes, reducing operational expenses, improving payment cycles, and enhancing audit readiness. Nym's solution identifies relevant clinical aspects, assigns codes, and provides an audit trail explaining its coding decisions. The company also has a research and development center in Tel Aviv-Yafo, Israel.

ClearScore

Private Equity Round in 2021
ClearScore is a financial technology company that offers credit scoring services and a marketplace aimed at improving users' financial well-being. The company provides access to crucial financial data, including credit reports and scores, as well as open banking data. Its platform is designed to assist users in consolidating personal debts and repaying them through low-interest, fixed-rate loans. By empowering individuals with these tools, ClearScore enables users to make informed and responsible decisions regarding debt management and financial planning.

Ocrolus

Venture Round in 2021
Ocrolus Inc. is a technology company that specializes in document automation for the financial sector. Founded in 2014 and based in New York, the company offers an intelligent automation platform that analyzes financial documents, enabling clients to automate manual data processes and enhance operational efficiency. Its solutions capture data from various sources, including e-statements and scanned documents, while performing algorithmic checks alongside reviews by fraud specialists. Ocrolus's platform supports a range of applications, including loan underwriting, account openings, and auditing, thereby facilitating credit decisions within fintech, mortgage, and banking industries. The company serves notable clients such as PayPal, Brex, and SoFi, and has raised over $100 million from leading fintech investors to bolster its innovative offerings.

Bitso

Series C in 2021
Bitso is a cryptocurrency exchange platform founded in 2014 and headquartered in Mexico City, Mexico. The company specializes in facilitating the buying and selling of bitcoin and other cryptocurrencies, providing users with a marketplace where they can trade fractions of various digital assets. Bitso's platform is designed for ease of use, allowing customers to conduct transactions and make payments via mobile devices. By focusing on the fintech and blockchain sectors, Bitso aims to enhance accessibility to cryptocurrency trading for users in Mexico and beyond.

Current

Series D in 2021
Current is a consumer fintech banking platform dedicated to enhancing financial access for everyday Americans. The company focuses on developing integrated solutions that address the barriers preventing individuals from achieving their financial goals. By simplifying banking processes and providing user-friendly tools, Current aims to empower users to build a secure financial future. With backing from prominent investors, Current continues to innovate in the financial technology space, striving to meet the diverse needs of its customer base through modern banking solutions.

RippleMatch

Venture Round in 2021
RippleMatch Inc. is an online recruiting service founded in 2015 and based in New York, New York. The company specializes in recruitment automation, transforming how Gen Z job seekers connect with potential employers. By replacing traditional job boards with a matching platform powered by artificial intelligence, RippleMatch streamlines the recruitment process for both candidates and employers, alleviating time-consuming tasks. Its services are utilized by prominent employers such as Amazon and eBay to foster diverse and high-performing teams. The platform assists early-career candidates in finding job opportunities after college, while also enabling employers to cultivate relationships with top students on college campuses. Through this innovative approach, RippleMatch is reshaping the landscape of job searching and recruitment for the next generation.

Zenflow

Series B in 2021
Zenflow, Inc. is a medical device company based in San Francisco, California, that specializes in providing innovative solutions for men suffering from benign prostatic hyperplasia (BPH) symptoms. Founded in 2014 by a team of Stanford University Biodesign Fellows in collaboration with leading urologists, the company aims to address the significant unmet clinical need for effective urinary obstruction treatments. Zenflow's primary product is a spring-like device designed to gently prop open the urethra, restoring its normal function without damaging surrounding tissues. This approach prioritizes patient comfort and minimizes invasiveness, offering a less painful alternative to traditional treatments for urinary obstruction caused by an enlarged prostate.

Descomplica

Series E in 2021
Descomplica is an online education platform based in Rio de Janeiro, Brazil, founded in 2011. The company specializes in providing students with access to a wide range of educational resources, including pre-recorded and live classes across various subjects, particularly focusing on mathematics, physics, and chemistry. Descomplica aims to facilitate college entrance exam preparation by offering affordable and high-quality educational materials, enabling students to learn at their own pace. The platform also features online monitoring to enhance the learning experience, making it accessible for a diverse group of learners seeking to achieve their academic goals.

Albert

Series C in 2021
Albert Corporation is a financial technology company established in 2015 and based in Culver City, California. The company offers a mobile application that provides financial advisory services designed to make money management accessible and affordable. Users can directly communicate with financial experts to address various financial issues, build personalized financial plans, and utilize automated investing services. The platform features tools for automatic savings, financial health monitoring, budgeting, and detailed spending reports. Additionally, it offers Albert Instant, which provides advances against paychecks to help customers avoid overdrafts. Albert aggregates financial data from users' bank accounts, credit cards, loans, and investments to analyze income and expenses, enabling personalized recommendations for savings accounts and loan applications. The company is supported by several investors, including General Atlantic and QED.

Presidio Medical

Series B in 2020
Presidio Medical, Inc. is a clinical-stage medical device company based in South San Francisco, California, that focuses on developing a neuromodulation technology platform aimed at treating chronic pain and other disorders affecting neuronal activity. Founded in 2017, the company is dedicated to creating a new class of therapeutic medical devices through its innovative bioelectronic medicine. This platform is designed to provide patients with effective remedies for conditions related to neural activity, positioning Presidio Medical at the forefront of advancements in medtech and bioengineering.

IonQ

Series B in 2020
IonQ, Inc. is a technology company that specializes in the development of general-purpose quantum information computers utilizing a trapped ion approach. Founded in 2015 and based in College Park, Maryland, IonQ focuses on advancing quantum computing capabilities through qubit replication, optical networkability, and optimized algorithms. The company's quantum computers represent a significant shift from classical computing, effectively addressing limitations associated with superposition and entanglement at the atomic level. IonQ provides access to its quantum processors through cloud platforms, offering quantum-computing-as-a-service (QCaaS) to a wide range of customers. Additionally, the company engages in research and development to enhance its quantum technology and supports clients through consulting services aimed at co-developing algorithms for its quantum systems.

BRIUS

Series A in 2020
Mechanodontics, Inc. is a Dallas, Texas-based company established in 2016 that specializes in the manufacture of a discreet dental device designed to move teeth independently. This innovative method serves as an alternative to traditional braces and aligners, offering significant advantages such as reduced treatment time, improved ease of cleaning, and enhanced comfort. The device is placed behind the teeth, making it virtually invisible, and is engineered to work on each tooth individually, allowing for more precise adjustments.

PACT Pharma

Series C in 2020
PACT Pharma, Inc. is a biotechnology company focused on developing personalized cell-based therapies for cancer treatment, specifically through neoantigen-specific adoptive T-cell therapies aimed at solid tumors. The company utilizes bioinformatics to analyze the DNA and RNA of patients' tumors and normal tissues, identifying candidate neoantigen peptides that can stimulate targeted antitumor T-cell responses. By recognizing unique neo-epitopes associated with individual cancers, PACT Pharma enables the engineering of autologous T cells designed to specifically target and eliminate tumor cells expressing these neoantigens. Founded in 2016 and based in South San Francisco, California, PACT Pharma is dedicated to advancing innovative treatment options for patients with cancer.

Finastra

Venture Round in 2020
Finastra is a global leader in financial services software, formed in 2017 through the merger of Misys and D+H. The company offers a comprehensive portfolio of solutions that encompass retail banking, transaction banking, lending, and treasury and capital markets. With a focus on open innovation, Finastra enables financial institutions of all sizes to deploy critical technology either on-premises or in the cloud. Its extensive range of offerings includes mortgage technology, payment management, and student lending solutions. Serving 48 of the world's top 50 banks, Finastra's secure and reliable platforms empower clients to enhance operations, mitigate risks, and adapt to the evolving demands of their customers. The company's broad geographical reach and scale ensure effective support for a diverse clientele, ranging from global financial institutions to community banks and credit unions.

Auris Health

Series E in 2018
Auris Health, Inc. is a medical technology company based in Redwood City, California, that specializes in the development of robotic systems for diagnostic and therapeutic procedures. Founded in 2007, the company is known for its Monarch Platform, which enhances endoscopic procedures by utilizing flexible robotics, advanced imaging technology, and micro-instrumentation. This platform allows for minimally invasive access to the body through natural openings using small cameras and tools, thereby improving patient outcomes and potentially reducing healthcare costs. Additionally, Auris Health is working on a dual-arm microsurgical system designed for ophthalmic surgery, further expanding its focus on innovative robotic solutions for various medical applications. Auris Health operates as a subsidiary of Johnson & Johnson.

Accommodations Plus International

Private Equity Round in 2018
Accommodations Plus International is a provider of lodging and ground transportation services, primarily catering to the airline, rail, and cruise industries. The company specializes in managing crew accommodations and logistics, which includes organizing hotel stays and transportation for airline crews and cruise staff. Their offerings encompass airline flight crew planning, property site inspections, ongoing account management, and analytics reporting. This comprehensive approach enables effective management of crew travel and distressed passenger services, ensuring that clients receive end-to-end support in their logistical needs.

Splash

Series C in 2018
Splash offers an online marketing automation platform designed to assist event marketers and field marketing teams in creating and executing virtual, in-person, and hybrid events. The platform enables users to build custom event websites, craft online invitations, manage ticket sales, and integrate attendee engagement with broader marketing efforts. By providing these tools, Splash empowers organizations to enhance their event marketing programs, ensuring they are on-brand, measurable, and compliant, while delivering memorable experiences that engage attendees and drive business value.

Descomplica

Series D in 2018
Descomplica is an online education platform based in Rio de Janeiro, Brazil, founded in 2011. The company specializes in providing students with access to a wide range of educational resources, including pre-recorded and live classes across various subjects, particularly focusing on mathematics, physics, and chemistry. Descomplica aims to facilitate college entrance exam preparation by offering affordable and high-quality educational materials, enabling students to learn at their own pace. The platform also features online monitoring to enhance the learning experience, making it accessible for a diverse group of learners seeking to achieve their academic goals.

Mexico Telecom Partners

Venture Round in 2017
Mexico Telecom Partners is a privately-owned company specializing in wireless telecommunications infrastructure. With ownership, management, or master leases of over 3,080 wireless sites, the company provides essential connectivity by leasing space on towers to telecommunications carriers and other wireless technology users. Additionally, Mexico Telecom Partners has developed various Distributed Antenna System (DAS) networks to enhance outdoor and indoor coverage, catering to locations that require specialized solutions. Their infrastructure network supports mobile phone operators and multiple fiber-optic service providers, ensuring reliable connectivity and data availability for end-users.

Global Fashion Group

Venture Round in 2017
Global Fashion Group S.A. is an e-commerce platform specializing in fashion and lifestyle markets across the Asia Pacific, Latin America, and the Commonwealth of Independent States. Founded in 2011 and headquartered in Senningerberg, Luxembourg, the company operates several prominent online brands, including The Iconic, Zalora, Dafiti, and Lamoda. It offers a diverse range of products, including fashion, sports, lifestyle, and premium collections, catering to evolving consumer preferences. By providing a seamless online shopping experience, Global Fashion Group enables brands to enter and thrive in emerging markets. The majority of its revenue is generated from its operations in Australia and New Zealand, particularly through The Iconic brand. In addition to e-commerce, the company also offers various services, including consultancy, IT support, and marketing solutions, enhancing its comprehensive approach to the fashion retail sector.

Nu

Venture Round in 2016
Nu is a financial services technology company.

Fundera

Series B in 2015
Fundera, Inc. is an online marketplace based in New York that assists small business owners in comparing diverse small business loan options. Founded in 2013, the platform features a wide range of financial products, including SBA loans, term loans, equipment financing, business lines of credit, invoice financing, short-term loans, merchant cash advances, and personal loans for business purposes. Fundera aims to empower entrepreneurs by providing expert insights and tailored financial options, allowing them to make informed decisions based on their specific needs and eligibility. By leveraging proprietary technology and financial expertise, Fundera connects business owners with lenders, credit card issuers, and banks to help them secure funding at competitive rates. As of October 2020, Fundera operates as a subsidiary of NerdWallet, Inc.

AqueSys

Series D in 2014
AqueSys, Inc. is an ophthalmic company based in Aliso Viejo, California, specializing in the development and commercialization of innovative implantable devices for glaucoma treatment. Founded in 2005, the company is known for its XEN gel stent, which facilitates the outflow of aqueous fluid from the anterior chamber to the subconjunctival space, effectively lowering intraocular pressure. This device creates a new drainage pathway, enhancing patient outcomes in glaucoma management. AqueSys operates as a subsidiary of Allergan plc, focusing on advancing surgical solutions to improve eye health.

CardioGard Medical

Seed Round in 2011
CardioGard develops a specially designed arterial cannula for the removal of gaseous material during heart bypass surgeries. The system is composed of a double-lumen cannula in which the primary lumen provides oxygenated blood from the heart-lung machine to the patient and a secondary lumen suctions blood and embolic matter away from the surgical field and back to the cardiopulmonary bypass machine for the filtration.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.